Entity Common Stock, Shares Outstanding of Syros Pharmaceuticals, Inc. from 12 Aug 2016 to 24 Oct 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Syros Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Aug 2016 to 24 Oct 2024.
  • Syros Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 24 Oct 2024 was 26,832,457.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Syros Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 26,832,457 24 Oct 2024 10-Q 31 Oct 2024 2024 Q3
Q1 2024 26,453,891 +6,153,472 +30% 06 Mar 2024 10-K 27 Mar 2024 2023 FY
Q2 2023 20,710,046 -42,295,249 -67% 04 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 20,300,419 -41,782,578 -67% 27 Feb 2023 10-K 02 Mar 2023 2022 FY
Q3 2022 20,225,921 -41,721,229 -67% 10 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 63,005,295 +1,074,495 +1.7% 08 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 62,082,997 +224,730 +0.36% 11 Mar 2022 10-K 15 Mar 2022 2021 FY
Q3 2021 61,947,150 +16,136,415 +35% 31 Oct 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 61,930,800 +16,168,631 +35% 31 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 61,858,267 +16,165,099 +35% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 45,810,735 +3,369,508 +7.9% 31 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 45,762,169 +3,323,925 +7.8% 31 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 45,693,168 +3,258,388 +7.7% 30 Apr 2020 10-Q 07 May 2020 2020 Q1
Q3 2019 42,441,227 +8,786,623 +26% 31 Oct 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 42,438,244 +8,783,855 +26% 26 Jul 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 42,434,780 +9,856,460 +30% 26 Apr 2019 10-Q 01 May 2019 2019 Q1
Q3 2018 33,654,604 +7,358,168 +28% 26 Oct 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 33,654,389 +7,394,186 +28% 31 Jul 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 32,578,320 +9,185,402 +39% 30 Apr 2018 10-Q 10 May 2018 2018 Q1
Q3 2017 26,296,436 +2,915,967 +12% 31 Oct 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 26,260,203 +2,885,832 +12% 31 Jul 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 23,392,918 28 Feb 2017 10-K 20 Mar 2017 2016 FY
Q3 2016 23,380,469 09 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 23,374,371 12 Aug 2016 10-Q 15 Aug 2016 2016 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.